Access expired on Sunday, November 10, 2024
This content was originally shared by a registered user, but access has expired. Create a free account to gain permanent access to all PracticeUpdate content.
Already Have An Account? Log in Now
featured
Molecular Profiling of BRAF V600E–Mutant Metastatic Colorectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Nature Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Molecular profiling of BRAF-V600E-mutant metastatic colorectal cancer in the phase 3 BEACON CRC trial
Nat. Med. 2024 Sep 23;[EPub Ahead of Print], S Kopetz, DA Murphy, J Pu, F Ciardiello, J Desai, E Van Cutsem, HS Wasan, T Yoshino, H Saffari, X Zhang, P Hamilton, T Xie, R Yaeger, J TaberneroFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.